Biogen Inc. (BIIB)
NASDAQ·Healthcare·Drug Manufacturers - General
$199.25
-0.36%
Mkt Cap $28.84B
Analyst Ratings
Buy
17
Hold
17
Sell
0
Price Target (117 analysts)
$207.60
Range $143.00 – $250.00
Implied Upside
+4.2%
Consensus $207.60 vs current $199.25